BAE Systems raises FY26 outlook as H1 sales climb 9% and free cash flow hits £1.79bn

BAE Systems plc (LON: BA., OTC: BAESY), the FTSE 100 defence prime, published its half-year results for the six months ended 30 June 2026 on 30 July 2026 and simultaneously upgraded every headline metric in its full-year guidance. Sales rose 9% on a constant-currency basis to £15,772m, underlying earnings before interest and tax (EBIT) rose 11% to £1,701m, underlying earnings per share climbed 13% to 38.9p, and free cash flow swung to a £1,791m inflow from a £368m outflow in the prior-year period. Chief Executive Charles Woodburn said the performance across the portfolio gave management the confidence to lift full-year sales, EBIT, EPS and free cash flow ranges together. Yet BAE Systems’ American Depositary Receipts (OTC: BAESY) fell 8.3% in after-hours trading to $98.79 from a regular-session close of $107.73, signalling that a stock trading on roughly 30 times trailing earnings had already priced in a substantial upgrade and demanded more.

How does BAE Systems’ H1 2026 delivery justify the second guidance upgrade in three months?

The half-year numbers cleared every previously communicated bar. All five business sectors contributed to sales growth. Underlying return on sales rose modestly to 10.8% from 10.6%, EBIT growth of 11% ran ahead of the 9% top line, and the underlying EPS growth of 13% reflected a lower underlying finance cost line, now guided to around £340m for the full year against a previous expectation of £370m. Order intake of £16.4bn was 24% higher than the £13.2bn reported in the first half of 2025, and the order backlog reached a record £84.0bn. On the IFRS-defined view, revenue grew 8% to £14,615m and operating profit rose 13% to £1,504m as amortisation of acquired intangibles and adjusting items eased. In practical terms, the group extended the operating momentum reported in its February preliminary results and May 2026 trading update rather than encountering the pace of moderation that had increasingly concerned parts of the sell side. Kepler Cheuvreux had earlier warned that BAE Systems was priced for perfection; the first half instead pushed guidance ranges wider on the upside.

Management’s new full-year framework raises sales growth to 8% to 10% from 7% to 9%, underlying EBIT growth to 10% to 12% from 9% to 11%, underlying EPS growth to 11% to 13% from 9% to 11%, and the free cash flow target to more than £2.0bn from more than £1.3bn. The cumulative 2024 to 2026 free cash flow target moved to more than £6.7bn from more than £6.0bn. Together, that is a rare simultaneous lift across every measure the company guides.

Why did BAE Systems shares fall 8.3% after hours despite every headline number being raised?

The apparent contradiction rests on three factors that institutional investors were watching before the print. First, the pre-results valuation had already discounted a strong half. BAE Systems shares had rallied heavily in 2025 and into 2026, taking the forward multiple into the low-to-mid twenties on London and closer to 30 times trailing earnings on the OTC line. A second guidance upgrade in the space of three months was substantial but not out of consensus. Second, the composition of the free cash flow inflow drew attention. The company disclosed that the £1,791m first-half inflow reflected a high level of customer advances, with no material advances received in the comparative period. Net cash flow from operating activities under IFRS moved to £2,243m from £74m, a movement that also includes advance-related working capital timing. The mix means the headline swing overstates the run rate of operational cash generation.

Third, and less discussed, the guidance table itself contained a subtle signal. While the 2024-to-2026 cumulative free cash flow target was raised by £700m, the 2025-to-2027 and 2026-to-2028 cumulative free cash flow ranges were left unchanged. That construction implies management sees the current-year uplift as at least partly a timing pull-forward from later years rather than a permanent step change in structural cash generation. For a stock priced on the assumption that defence-cycle economics will keep compounding for years, that nuance carries more weight than the headline upgrade in isolation.

How does the £1.79bn free cash flow inflow change the capital-return runway from here?

BAE Systems returned £933m to shareholders through dividends and buybacks in the first half, a 10% year-on-year increase, and the Board declared an interim dividend of 15.0p, payable on 2 December 2026 and up 11% on the prior interim. The company sits within a three-year £1.5bn buyback programme launched in 2024, and management has continued to execute against it. The upgraded free cash flow target of more than £2.0bn for 2026, if delivered on a more normalised advances profile in the second half, would leave BAE Systems with enough cash generation to fund both distributions and its ongoing capacity investment programme without disturbing balance-sheet flexibility. The immediate question is not whether the current distribution pace is sustainable, but whether it can grow at a rate that keeps up with the stock’s implied earnings-growth expectations.

The complication is that a large share of the H1 cash uplift came from customer prepayments tied to contracts that must still be executed. Advances flatter cash-flow reporting today, but the revenue and margin recognition tail can be long, and delivery-phase working capital tends to reverse the effect. Investors watching the cadence of shareholder returns into 2027 and 2028 will place more weight on the unchanged forward cumulative cash targets than on the 2026-only lift.

What do the Brontanax, Edgewing GCAP and Dreadnought wins say about long-cycle order visibility?

The order intake mix in the first half was heavy with long-dated, franchise-defining programmes. Edgewing, the joint venture at the centre of the Global Combat Air Programme (GCAP) between the United Kingdom, Italy and Japan, secured its first international contracts with a combined value in excess of £5bn, unlocking completion of the advanced concept and assessment phase and further joint design and development work. On the domestic front, BAE Systems is set to receive a new £5.9bn contract to fund critical work on the United Kingdom’s Dreadnought Class nuclear deterrent submarines, to be announced at its Barrow-in-Furness site. In parallel, BAE Systems unveiled Brontanax at the Farnborough International Airshow in July, presenting what it describes as the United Kingdom’s first uncrewed autonomous Collaborative Combat Aircraft, designed and built at the company’s Warton site to provide electronic warfare and precision strike capabilities alongside crewed aircraft.

Together, these programmes stretch order visibility well into the 2030s and align BAE Systems with the two most consequential emerging defence architectures for its home nation: sovereign next-generation combat air and the successor submarine deterrent. The strategic implication for investors is that a growing share of the £84.0bn backlog is tied to programmes that governments are highly unlikely to unwind, even under fiscal pressure. The trade-off is that these are also long-cycle, cost-plus-and-risk-sharing type engagements where margin evolution depends on delivery discipline rather than pricing power.

How is the US munitions and ICBM investment programme reshaping BAE Systems’ North American footprint?

BAE Systems has continued to lean into United States capacity build-out. The company signed a seven-year framework agreement with the US Department of War (DoW) to quadruple production and accelerate delivery of the infrared seeker for the Terminal High Altitude Area Defense (THAAD) interceptor missile, an award linked to the DoW’s Acquisition Transformation Strategy. It also secured a further $535m (£398m) M109A7 Paladin Self-Propelled Howitzer award, over $200m of ARCHER artillery contracts and $180m of TRIDON Mk2 anti-aircraft and counter-drone contracts through its Bofors business in Sweden. It completed the Preliminary Design Review for the $1.2bn Epoch 2 missile warning and tracking satellite programme within nine months of the US Space Force contract award, while receiving $373m of incremental funding in the period.

To support that revenue, the company opened a new facility in Utah supporting Intercontinental Ballistic Missile sustainment and modernisation, completed a 150,000 sq-ft expansion of its Endicott campus in New York, and announced $135m of further investment across sites in Austin, Texas and Hudson, New Hampshire to expand precision-guided munitions production capacity. Individually, these are incremental. Taken together, they indicate that BAE Systems is positioning to capture a disproportionate share of the current United States effort to rebuild critical munitions and strategic-forces infrastructure. The commercial question is how quickly the invested capacity converts into contribution margin and whether US administrative decisions on defence procurement remain aligned with the pace of ramp-up.

Where does the record £84.0bn order backlog sit in the conversion-to-revenue debate?

A backlog of £84.0bn against annualised sales of roughly £31bn implies close to two and a half years of forward revenue coverage. The order intake to sales ratio in the first half was above 1.0x, sustaining that coverage even as revenue ran ahead of the prior year. The under-recognised nuance for BAE Systems is the difference between the Group backlog measure of £84.0bn, which includes share of equity accounted investments such as MBDA and Eurofighter partner arrangements, and the IFRS order book of £62.7bn, which fell marginally from £63.1bn at 31 December 2025. That difference explains why a company with a record top-line backlog can still see its IFRS order book move sideways in a strong intake period, and why analysts modelling revenue recognition on IFRS lines can arrive at more measured growth trajectories than the group-level narrative suggests.

For investors, the useful test in the second half will be less about backlog size and more about the pace at which specific long-duration programmes such as GCAP, Dreadnought, THAAD seeker production and the US munitions ramp translate into recognised revenue and margin. Backlog is a necessary condition for the current investment thesis; it is not sufficient at the multiple the stock still commands.

What would strengthen or weaken the BAE Systems investment thesis into the second half of 2026?

The first half strengthens the operating case unambiguously. Sales, EBIT, EPS and cash all grew, the guidance ranges have been reset upward, order intake and backlog reached new highs, and returns to shareholders continued to grow in step with earnings. Currency and interest-cost tailwinds are helping the reported figures, but the underlying delivery is solid across all sectors.

The offsetting considerations are three. First, the size of the free cash flow beat is inflated by customer advances that will not repeat in every period, a point that management has been transparent about and that is reinforced by the decision to leave the 2025-to-2027 and 2026-to-2028 cumulative cash targets unchanged. Second, the after-hours share-price reaction indicates that the market’s threshold for a positive share-price response is now materially higher than a simple upgrade of every guidance line. Third, currency sensitivity remains meaningful: management notes that a five-cent movement in the sterling-dollar exchange rate affects sales by around £500m and EBIT by around £70m, which cuts in both directions.

The next measurable proof points are the full-year 2026 results in February 2027, which will show whether operational cash conversion outside the advances effect matches the guidance, and the pace at which recently signed Edgewing GCAP, THAAD framework, Dreadnought and Australia-Canada Arctic radar programmes convert to IFRS revenue during the second half of 2026 and the first half of 2027.

Key takeaways for investors following BAE Systems’ upgraded 2026 half-year results

• BAE Systems plc delivered 9% constant-currency sales growth to £15,772m and 11% underlying EBIT growth to £1,701m in the first half of 2026, with all five sectors contributing to the top-line advance.
• Every full-year 2026 guidance line was upgraded: sales growth to 8% to 10%, underlying EBIT growth to 10% to 12%, underlying EPS growth to 11% to 13%, and free cash flow to more than £2.0bn.
• The £1,791m free cash flow inflow was materially supported by customer advances, which were absent in the comparative period, so the swing overstates the underlying run rate of cash generation.
• Cumulative free cash flow guidance for 2024 to 2026 was raised by £700m, but the 2025 to 2027 and 2026 to 2028 cumulative ranges were left unchanged, implying a timing pull-forward rather than a permanent step change.
• Order intake of £16.4bn drove the backlog to a record £84.0bn on the Group definition, though the IFRS order book edged down to £62.7bn from £63.1bn at 31 December 2025.
• Strategic first-half wins included Edgewing’s first international GCAP contracts above £5bn, a £5.9bn Dreadnought Class submarine contract, and a seven-year US Department of War framework for THAAD interceptor seeker production.
• BAE Systems is expanding United States precision-guided munitions and missile capacity across Utah, New York, Texas and New Hampshire, positioning for the current effort to rebuild critical stockpiles and strategic-forces infrastructure.
• Capital returns reached £933m in the first half through dividends and buybacks, up 10% year on year, and the interim dividend was declared at 15.0p, an 11% increase.
• Despite the operational strength and guidance uplift, BAE Systems’ OTC American Depositary Receipts fell 8.3% after hours to $98.79, indicating the market’s threshold for a positive share-price response is now well above a straightforward upgrade to every headline metric.
• The next tests are the pace of cash conversion outside customer advances in the second half and the revenue and margin recognition curve on GCAP, Dreadnought, THAAD and the US munitions programmes.